SCOUT Radar Localization In EMEA

Merit Oncology Expands to Europe, Middle East & Africa (EMEA) to Treat More Patients Globally

Merit Oncology’s newest technology is SCOUT^® Radar Localization, an advanced wire-free radar localization system designed to improve the precision and predictability of marking tumors, biopsy sites, and lymph nodes prior to neoadjuvant therapy and surgery. SCOUT Radar Localization is the wire-free platform that exclusively spans the care continuum from biopsy to surgery. Launched in the United States in 2015, more than 885 consoles have been placed, SCOUT has been used in over 180,000 procedures and is supported by over 45 clinical publications.

SCOUT Radar Localization - Preferred Solution to Treat More Patients - Merit Oncology

More Than
885
Consoles

180K
Procedures

45+
Clinical
Publications

AN EXPERIENCE WITH SCOUT — FEATURED ON THE BBC

The Royal Free Hospital in London with surgeon, Mr Debashis Ghosh, were one of the first HNS hospitals to use SCOUT in the UK. Watch one of their first patient’s experiences with SCOUT in a November segment on the BBC.

CLINICAL PUBLICATIONS

Wire-free localization is quickly becoming the standard of care for achieving optimal clinical results while providing patients a better overall experience. Since its approval in Europe in March, 2020, SCOUT has been referenced in two European publications.

Reflector-guided Localization of Non-palpable Breast Lesions: The First Reported European Evaluation of the SAVI SCOUT System

Background: Wire-guided localization (WGL) has been the mainstay for localizing non-palpable breast lesions before excision. Due to its limitations, various wireless alternatives have been developed. In this prospective study, we evaluate the role of radiation-free wireless localization using the SAVI SCOUT localization at a European centre.

Savi SCOUT Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases

Background/Aim: With the increase in detection of non-palpable breast lesions through screening, wire-guided localisation (WGL) has long been the favoured method for preoperative localisation. However, this technique comes with several limitations. New methods have been developed, including several non-radioactive, wireless options. We aimed to assess the effectiveness of Savi Scout localisation (SSL) through this pooled analysis and systematic review.

Chat with usLiveChat

Merit Oncology Expands to Europe, Middle East & Africa (EMEA) to Treat More Patients Globally

AN EXPERIENCE WITH SCOUT — FEATURED ON THE BBC

CLINICAL PUBLICATIONS

Reflector-guided Localization of Non-palpable Breast Lesions: The First Reported European Evaluation of the SAVI SCOUT System

Savi SCOUT Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases

Divisions

Contact

Connect

Merit Oncology Expands to Europe, Middle East & Africa (EMEA) to Treat More Patients Globally

AN EXPERIENCE WITH SCOUT — FEATURED ON THE BBC

CLINICAL PUBLICATIONS

Reflector-guided Localization of Non-palpable Breast Lesions: The First Reported European Evaluation of the SAVI SCOUT System

Savi SCOUT Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases

Share this page

Divisions

Contact

Connect